Stay updated on Nivolumab in Refractory Biliary Tract Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, replacing the detailed trial content. Added 403-related markup and basic navigation text while several study-related references were removed.
    Difference
    18%
    Check dated 2026-09-22T06:41:32.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    The page's revision label changed from v3.6.5 to v3.6.6, signaling a new deployment of the page; this is a system-level update rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-08-31T23:33:14.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.4 to v3.6.5, indicating a small template or system update for the study page.
    Difference
    0.1%
    Check dated 2026-08-10T12:20:49.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4. This indicates a minor update to the study page metadata without changing its content.
    Difference
    0.1%
    Check dated 2026-07-27T06:23:06.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Footer now includes references to the Moffitt Clinical Trials website and sponsor organization, plus a 'Helpful Links Provided by' attribution. The revision tag has been updated from v3.6.2 to v3.6.3.
    Difference
    0.2%
    Check dated 2026-07-05T12:25:32.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.0 to v3.6.2. This indicates a newer page build without changes to the study content or data.
    Difference
    0.1%
    Check dated 2026-06-28T08:48:49.000Z thumbnail image

Stay in the know with updates to Nivolumab in Refractory Biliary Tract Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Refractory Biliary Tract Cancers Clinical Trial page.